OMX Nordic 40
2.468,22
PKT
-21,57
PKT
-0,87
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.01.18 | Novo Nordisk buy | UBS AG | |
08.01.18 | AstraZeneca Neutral | UBS AG | |
08.01.18 | Nokia overweight | JP Morgan Chase & Co. | |
05.01.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
05.01.18 | Nokia Neutral | Credit Suisse Group | |
05.01.18 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
04.01.18 | Nokia Strong Buy | S&P Capital IQ | |
03.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
20.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
14.12.17 | ABB (Asea Brown Boveri) kaufen | Kepler Cheuvreux | |
12.12.17 | Nokia overweight | JP Morgan Chase & Co. | |
12.12.17 | Novo Nordisk buy | UBS AG | |
12.12.17 | Volvo (B) Neutral | UBS AG | |
12.12.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
11.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
08.12.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
07.12.17 | Novo Nordisk Reduce | HSBC | |
06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
06.12.17 | Novo Nordisk buy | UBS AG | |
06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
06.12.17 | Fortum Sell | Deutsche Bank AG | |
06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
05.12.17 | AstraZeneca buy | Deutsche Bank AG | |
04.12.17 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
02.12.17 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
30.11.17 | Nokia Neutral | BNP PARIBAS | |
29.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
29.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
28.11.17 | Novo Nordisk buy | UBS AG | |
24.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
24.11.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley |